logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Inflammation

    FiltersReset Filters
    20 results

    • acular

      (Ketorolac Tromethamine)
      Allergan, Inc.
      Usage: ACULAR® ophthalmic solution is indicated for temporary relief of ocular itching from seasonal allergic conjunctivitis and for treating postoperative inflammation following cataract extraction.

    • bromfenac

      (bromfenac)
      Sun Pharmaceutical Industries, Inc.
      Usage: Bromfenac ophthalmic solution 0.075% is indicated for treating postoperative inflammation and preventing ocular pain in patients following cataract surgery.

    • bromfenac

      (Bromfenac)
      Amneal Pharmaceuticals NY LLC
      Usage: Bromfenac ophthalmic solution, 0.07% is indicated for treating postoperative inflammation and reducing ocular pain in patients following cataract surgery.

    • bromfenac

      (BROMFENAC)
      Lupin Pharmaceuticals Inc
      Usage: Bromfenac ophthalmic solution, 0.075%, is indicated for treating postoperative inflammation and preventing ocular pain in patients who have undergone cataract surgery.

    • bromfenac ophthalmic solution

      (Bromfenac Sodium)
      Dr. Reddy's Laboratories Inc.
      Usage: Bromfenac Ophthalmic Solution 0.07% is indicated for treating postoperative inflammation and reducing ocular pain in patients following cataract surgery.

    • bromfenac ophthalmic solution

      (Bromfenac Sodium)
      Bausch & Lomb Americas Inc.
      Usage: Bromfenac Ophthalmic Solution 0.07% is indicated for treating postoperative inflammation and reducing ocular pain in patients following cataract surgery.

    • clobetasol propionate

      (CLOBETASOL PROPIONATE)
      Eyenovia, Inc.
      Usage: BYQLOVI is indicated for treating post-operative inflammation and pain after ocular surgery.

    • dexamethasone

      (Dexamethasone)
      Rising Pharma Holdings, Inc.
      Usage: This drug is indicated for various conditions, including endocrine and rheumatic disorders, collagen diseases, severe allergic states, ophthalmic and respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, gastrointestinal diseases, and certain miscellaneous conditions, as well as for diagnostic testing of adrenocortical hyperfunction.

    • dexamethasone sodium phosphate

      (Dexamethasone Sodium Phosphate)
      Mylan Institutional LLC
      Usage: This drug is indicated for various conditions, including adrenal insufficiencies, rheumatic disorders, collagen diseases, severe allergic reactions, ophthalmic, gastrointestinal, respiratory, hematologic, and neoplastic diseases, and for reducing edema. It can be administered intravenously, intramuscularly, intra-articularly, or intralesionally, depending on the condition.

    • dexamethasone sodium phosphate

      (Dexamethasone Sodium Phosphate)
      Civica, Inc.
      Usage: This drug is indicated for various conditions, including endocrine disorders (like adrenocortical insufficiency), rheumatic and collagen diseases, severe allergic reactions, dermatologic and gastrointestinal diseases, respiratory issues, hematologic conditions, neoplastic diseases, and neurological disorders. It can be administered intravenously, intramuscularly, intra-articularly, or intralesionally as appropriate.